"ADHD Medication Recall: 8,500 Bottles of Trusted Drug"

"ADHD Medication Recall: 8,500 Bottles of Trusted Drug"

ADHD Medication Recall: What You Need to Know

Starting a new school year can be challenging for any student, but for the millions of children in the U.S. with attention-deficit hyperactivity disorder (ADHD), it can bring additional obstacles. Recent shortages of ADHD medications have added stress for many individuals, prompting calls for healthcare policies to support those affected.

Research published in Frontiers in Pharmacology indicates that about 6% of Americans have received an ADHD diagnosis, with approximately 33% using medications to manage the condition. The demand for these medications has been on the rise globally, leading to manufacturing issues and supply shortages.

The U.S. Food and Drug Administration (FDA) recently announced a recall of 8,544 bottles of Lisdexamfetamine Dimesylate capsules, a common medication for ADHD. This generic drug is known by brand names such as Vyvanse or Arynta and is used to treat both children (6 years and older) and adults with ADHD.

Details of the Recall

  • Lisdexamfetamine Dimesylate Capsules, 40 milligrams (mg)
  • 100-count bottles
  • Rx Only
  • Lot #: 25280726A
  • Expiration Date: 03/2027
  • Distributed by: Lannett Company, Inc., Philadelphia, PA 19136
  • NDC (National Drug Code): 0527-4664-37

The recall was issued due to a labeling mix-up where bottles labeled as 40mg capsules actually contained 30mg capsules. This discrepancy could result in patients receiving a lower dose than prescribed, potentially impacting treatment effectiveness.

Implications of the Recall

The FDA categorized this recall as a Class II event, indicating a possibility of temporary or reversible adverse health effects from the incorrect dosage. Patients who have been affected by this recall are advised to contact their healthcare provider for guidance on next steps.

The recalling firm, Lannett Company Inc., has a long history of producing generic pharmaceutical products. This is not the first time they have been involved in a recall related to Lisdexamfetamine Dimesylate, raising concerns about the quality control processes in place.

Stay Informed

For the latest updates on health and wellness news, subscribe to The Healthy newsletter and follow The Healthy on social media platforms like Facebook and Instagram. It's essential to stay informed about medication recalls and other health-related issues to protect your well-being.

The post More Than 8,500 Bottles of a Trusted ADHD Medication Have Been Recalled Nationwide appeared first on The Healthy.

Comments